REQUEST A DEMO
Total
USD $0.00
Search more companies

Boehringer Ingelheim Serbia D.O.O. Beograd (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Boehringer Ingelheim Serbia D.O.O. Beograd Profile Updated: October 13, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Boehringer Ingelheim Serbia D.O.O. Beograd is a company in Serbia, with a head office in Belgrade. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on October 21, 2009. The total number of employees is currently 40 (2019). The company’s latest financial report indicates a net sales revenue increase of 9.75% in 2022. Its total assets decreased by 2.48% over the same period. The net profit margin of Boehringer Ingelheim Serbia D.O.O. Beograd decreased by 0.03% in 2022.

Headquarters
Milentija Popovica 5A
Belgrade; Belgrade; Postal Code: 11000

Contact Details: Purchase the Boehringer Ingelheim Serbia D.O.O. Beograd report to view the information.

Website: http://www.boehringer-ingelheim.at

Basic Information
Total Employees:
Purchase the Boehringer Ingelheim Serbia D.O.O. Beograd report to view the information.
Outstanding Shares:
Purchase the Boehringer Ingelheim Serbia D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Boehringer Ingelheim Serbia D.O.O. Beograd report to view the information.
Incorporation Date:
October 21, 2009
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Boehringer Ingelheim Serbia D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
9.75%
Total operating revenue
9.75%
Operating profit (EBIT)
N/A
EBITDA
5592.35%
Net Profit (Loss) for the Period
8.6%
Total assets
-2.48%
Total equity
15.14%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-0.03%
Return on Equity (ROE)
-1.49%
Debt to Equity Ratio
-7.51%
Quick Ratio
-0.07%
Cash Ratio
-0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?